DJ Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ slipped 4.24% to $1.58 Friday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 2.01% to 21,647.61 and Dow Jones Industrial Average falling 0.96% to 45,577.47.
This was the stock's third consecutive day of losses.
Inovio Pharmaceuticals Inc. closed 46.96% below its 52-week high of $2.98, which the company achieved on September 9th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 0.94% to $235.37, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ fell 1.61% to $26.97.
Trading volume (988,583) remained 8,994 below its 50-day average volume of 997,577.
Data source: Dow Jones Market Data, FactSet. Data compiled March 20, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 20, 2026 17:26 ET (21:26 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments